SEC Form 4 · accession 0001140361-16-054520
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert B Catell
Director
Period of report
Feb 19, 2016
Accepted (ET)
Feb 23, 2016 · 2:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $3.70 | Feb 19, 2016 | A | 15,000 | A | — | Feb 19, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of February 19, 2017, 2018 and 2019.